These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 34753494)

  • 1. Therapeutic inhibition of GAS6-AS1/YBX1/MYC axis suppresses cell propagation and disease progression of acute myeloid leukemia.
    Zhou H; Liu W; Zhou Y; Hong Z; Ni J; Zhang X; Li Z; Li M; He W; Zhang D; Chen X; Zhu J
    J Exp Clin Cancer Res; 2021 Nov; 40(1):353. PubMed ID: 34753494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long noncoding RNA GAS6 antisense RNA1 silencing attenuates the tumorigenesis of acute myeloid leukemia cells through targeting microRNA-370-3p/Tetraspanin3 axis.
    Lei W; Lin J; Liu F; Chen N
    Clin Hemorheol Microcirc; 2021; 78(1):69-81. PubMed ID: 33523043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA UCA1 modulates cell proliferation and apoptosis by regulating miR-296-3p/Myc axis in acute myeloid leukemia.
    Li J; Wang M; Chen X
    Cell Cycle; 2020 Jun; 19(12):1454-1465. PubMed ID: 32286143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYC-Activated LncRNA
    Wu QN; Luo XJ; Liu J; Lu YX; Wang Y; Qi J; Liu ZX; Huang QT; Liu ZK; Lu JB; Jin Y; Pu HY; Hu PS; Zheng JB; Zeng ZL; Ju HQ; Xie D; Zhao Q; Xu R
    Cancer Res; 2021 May; 81(10):2636-2650. PubMed ID: 33782099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc suppresses miR-451⊣YWTAZ/AKT axis via recruiting HDAC3 in acute myeloid leukemia.
    Su R; Gong JN; Chen MT; Song L; Shen C; Zhang XH; Yin XL; Ning HM; Liu B; Wang F; Ma YN; Zhao HL; Yu J; Zhang JW
    Oncotarget; 2016 Nov; 7(47):77430-77443. PubMed ID: 27764807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing long non-coding RNA XIST suppresses drug resistance in acute myeloid leukemia through down-regulation of MYC by elevating microRNA-29a expression.
    Wang C; Li L; Li M; Wang W; Liu Y; Wang S
    Mol Med; 2020 Nov; 26(1):114. PubMed ID: 33228517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YBX1/lncRNA SBF2-AS1 interaction regulates proliferation and tamoxifen sensitivity via PI3K/AKT/MTOR signaling in breast cancer cells.
    Hussain SA; Venkatesh T
    Mol Biol Rep; 2023 Apr; 50(4):3413-3428. PubMed ID: 36754932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
    Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
    Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding antisense RNA GAS6-AS1 supports gastric cancer progression via increasing GAS6 expression.
    Zhang P; Dong Q; Zhu H; Li S; Shi L; Chen X
    Gene; 2019 May; 696():1-9. PubMed ID: 30735718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. YBX1 mediates translation of oncogenic transcripts to control cell competition in AML.
    Perner F; Schnoeder TM; Xiong Y; Jayavelu AK; Mashamba N; Santamaria NT; Huber N; Todorova K; Hatton C; Perner B; Eifert T; Murphy C; Hartmann M; Hoell JI; Schröder N; Brandt S; Hochhaus A; Mertens PR; Mann M; Armstrong SA; Mandinova A; Heidel FH
    Leukemia; 2022 Feb; 36(2):426-437. PubMed ID: 34465866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent manner.
    Feng M; Xie X; Han G; Zhang T; Li Y; Li Y; Yin R; Wang Q; Zhang T; Wang P; Hu J; Cheng Y; Gao Z; Wang J; Chang J; Cui M; Gao K; Chai J; Liu W; Guo C; Li S; Liu L; Zhou F; Chen J; Zhang H
    Blood; 2021 Jul; 138(1):71-85. PubMed ID: 33763698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct and indirect targeting of MYC to treat acute myeloid leukemia.
    Brondfield S; Umesh S; Corella A; Zuber J; Rappaport AR; Gaillard C; Lowe SW; Goga A; Kogan SC
    Cancer Chemother Pharmacol; 2015 Jul; 76(1):35-46. PubMed ID: 25956709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LncRNA DSCAM-AS1 interacts with YBX1 to promote cancer progression by forming a positive feedback loop that activates FOXA1 transcription network.
    Zhang Y; Huang YX; Wang DL; Yang B; Yan HY; Lin LH; Li Y; Chen J; Xie LM; Huang YS; Liao JY; Hu KS; He JH; Saw PE; Xu X; Yin D
    Theranostics; 2020; 10(23):10823-10837. PubMed ID: 32929382
    [No Abstract]   [Full Text] [Related]  

  • 14. Myc-Miz1 signaling promotes self-renewal of leukemia stem cells by repressing Cebpα and Cebpδ.
    Zhang L; Li J; Xu H; Shao X; Fu L; Hou Y; Hao C; Li W; Joshi K; Wei W; Xu Y; Zhang F; Dai S; Breslin P; Zhang J; Zhang J
    Blood; 2020 Apr; 135(14):1133-1145. PubMed ID: 32040550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic Long Noncoding RNA DARS-AS1 in Childhood Acute Myeloid Leukemia by Binding to microRNA-425.
    Dou B; Jiang Z; Chen X; Wang C; Wu J; An J; Sheng G
    Technol Cancer Res Treat; 2020; 19():1533033820965580. PubMed ID: 33073700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. lncRNA FBXL19-AS1 is a diagnosis biomarker for paediatric patients with acute myeloid leukemia.
    Sheng H; Zhang J; Ma Y; Zhang Y; Dai Y; Jiang R
    J Gene Med; 2021 Mar; 23(3):e3317. PubMed ID: 33474753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Wilms' tumor 1 associating protein expression predicts poor prognosis in acute myeloid leukemia and regulates m
    Naren D; Yan T; Gong Y; Huang J; Zhang D; Sang L; Zheng X; Li Y
    J Cancer Res Clin Oncol; 2021 Jan; 147(1):33-47. PubMed ID: 32880751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Molecular Signaling Pathways and Cytokine Responses to Modulate c-MYC in Acute Myeloid Leukemia.
    Gu K; May HA; Kang MH
    Front Biosci (Schol Ed); 2024 Sep; 16(3):15. PubMed ID: 39344393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kinases IKBKE and TBK1 regulate MYC-dependent survival pathways through YB-1 in AML and are targets for therapy.
    Liu S; Marneth AE; Alexe G; Walker SR; Gandler HI; Ye DQ; Labella K; Mathur R; Toniolo PA; Tillgren M; Gokhale PC; Barbie D; Mullally A; Stegmaier K; Frank DA
    Blood Adv; 2018 Dec; 2(23):3428-3442. PubMed ID: 30504235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ELK1-Induced upregulation of long non-coding TNK2-AS1 promotes the progression of acute myeloid leukemia by EZH2-mediated epigenetic silencing of CELF2.
    Guo D; Zhang A; Suo M; Wang P; Liang Y
    Cell Cycle; 2023 Jan; 22(1):117-130. PubMed ID: 35941836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.